Iwanaga T, Kishikawa R, Ikeda T, Hirose T, Tsurutani H, Yoshida S
Pulmonary Medicine, National Minami-Fukuoka Chest Hospital, Japan.
Kekkaku. 1998 Oct;73(10):579-84.
Pulmonary mycobacteriosis is usually caused by Mycobacterium tuberculosis, Mycobacterium avium complex, or Mycobacterium kansasii. There are, however, other slow-growing mycobacteria which can cause pulmonary infection. Mycobacterium szulgai, first reported in 1972, is a scotochromogenic species which can affect human lungs, although human-to-human spread of infection is thought to be unlikely. We have recently treated three cases of middle-aged to elderly persons (45-87 year-old), two of them had underlying diseases (one with intrapulmonary and the other with extrapulmonary). All patients had constitutional symptoms (cough, sputum, dyspnea), and chest roentgenograms demonstrated either cavitation with scattered nodules or peripheral infiltrates predominantly in upper lobes, resembling pulmonary tuberculosis. In two cases, M. szulgai was identified by using DNA-DNA hybridization method. The in vitro susceptibility of M. szulgai to antimycobacterial drugs was better than that of M. avium complex, and it was resistant only to paraaminosalicylate, cycloserine, and partially to isoniazid. Pulmonary disease of three patients were successfully treated with a combination of multiple antimycobacterial agents including rifampin, ethambutol, isoniazid, or streptomycin.
肺部分枝杆菌病通常由结核分枝杆菌、鸟分枝杆菌复合群或堪萨斯分枝杆菌引起。然而,还有其他生长缓慢的分枝杆菌可导致肺部感染。1972年首次报道的苏尔加分枝杆菌是一种暗产色菌,可感染人类肺部,不过一般认为其不会在人与人之间传播。我们最近治疗了3例中老年患者(年龄在45至87岁之间),其中2例有基础疾病(1例有肺部疾病,另1例有肺外疾病)。所有患者均有全身症状(咳嗽、咳痰、呼吸困难),胸部X线片显示有空洞并伴有散在结节,或主要在上叶的外周浸润影,类似肺结核。在2例患者中,通过DNA-DNA杂交法鉴定出了苏尔加分枝杆菌。苏尔加分枝杆菌对抗分枝杆菌药物的体外敏感性优于鸟分枝杆菌复合群,仅对对氨基水杨酸、环丝氨酸耐药,对异烟肼部分耐药。3例患者的肺部疾病通过联合使用多种抗分枝杆菌药物(包括利福平、乙胺丁醇、异烟肼或链霉素)成功治愈。